423 related articles for article (PubMed ID: 26369960)
21. Outsmarting metallo-beta-lactamases by mimicking their natural evolution.
Oelschlaeger P
J Inorg Biochem; 2008 Dec; 102(12):2043-51. PubMed ID: 18602162
[TBL] [Abstract][Full Text] [Related]
22. Broad antibiotic resistance profile of the subclass B3 metallo-β-lactamase GOB-1, a di-zinc enzyme.
Horsfall LE; Izougarhane Y; Lassaux P; Selevsek N; Liénard BM; Poirel L; Kupper MB; Hoffmann KM; Frère JM; Galleni M; Bebrone C
FEBS J; 2011 Apr; 278(8):1252-63. PubMed ID: 21299838
[TBL] [Abstract][Full Text] [Related]
23. Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1.
Majiduddin FK; Palzkill T
Antimicrob Agents Chemother; 2005 Aug; 49(8):3421-7. PubMed ID: 16048956
[TBL] [Abstract][Full Text] [Related]
24. Structural insights into the substrate specificity of IMP-6 and IMP-1 metallo-β-lactamases.
Yamamoto K; Tanaka H; Kurisu G; Nakano R; Yano H; Sakai H
J Biochem; 2022 Dec; 173(1):21-30. PubMed ID: 36174533
[TBL] [Abstract][Full Text] [Related]
25. Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.
Materon IC; Palzkill T
Protein Sci; 2001 Dec; 10(12):2556-65. PubMed ID: 11714924
[TBL] [Abstract][Full Text] [Related]
26. His224 alters the R2 drug binding site and Phe218 influences the catalytic efficiency of the metallo-β-lactamase VIM-7.
Leiros HK; Skagseth S; Edvardsen KS; Lorentzen MS; Bjerga GE; Leiros I; Samuelsen Ø
Antimicrob Agents Chemother; 2014 Aug; 58(8):4826-36. PubMed ID: 24913158
[TBL] [Abstract][Full Text] [Related]
27. Characterization of purified New Delhi metallo-β-lactamase-1.
Thomas PW; Zheng M; Wu S; Guo H; Liu D; Xu D; Fast W
Biochemistry; 2011 Nov; 50(46):10102-13. PubMed ID: 22029287
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the First OXA-10 Natural Variant with Increased Carbapenemase Activity.
Kotsakis SD; Flach CF; Razavi M; Larsson DGJ
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397053
[TBL] [Abstract][Full Text] [Related]
29. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
30. Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.
Sacha P; Wieczorek P; Hauschild T; Zórawski M; Olszańska D; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(2):137-42. PubMed ID: 18519228
[TBL] [Abstract][Full Text] [Related]
31. Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.
Pfennigwerth N; Geis G; Gatermann SG; Kaase M
J Antimicrob Chemother; 2015 Jul; 70(7):1973-80. PubMed ID: 25835992
[TBL] [Abstract][Full Text] [Related]
32. Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase.
Iyobe S; Kusadokoro H; Ozaki J; Matsumura N; Minami S; Haruta S; Sawai T; O'Hara K
Antimicrob Agents Chemother; 2000 Aug; 44(8):2023-7. PubMed ID: 10898670
[TBL] [Abstract][Full Text] [Related]
33. Structural insights into the subclass B3 metallo-β-lactamase SMB-1 and the mode of inhibition by the common metallo-β-lactamase inhibitor mercaptoacetate.
Wachino J; Yamaguchi Y; Mori S; Kurosaki H; Arakawa Y; Shibayama K
Antimicrob Agents Chemother; 2013 Jan; 57(1):101-9. PubMed ID: 23070156
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the active-site residues asparagine 167 and lysine 161 of the IMP-1 metallo beta-lactamase.
Haruta S; Yamamoto ET; Eriguchi Y; Sawai T
FEMS Microbiol Lett; 2001 Apr; 197(1):85-9. PubMed ID: 11287151
[TBL] [Abstract][Full Text] [Related]
35. The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
Palacios AR; Mojica MF; Giannini E; Taracila MA; Bethel CR; Alzari PM; Otero LH; Klinke S; Llarrull LI; Bonomo RA; Vila AJ
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348667
[TBL] [Abstract][Full Text] [Related]
36. Site-saturation studies of beta-lactamase: production and characterization of mutant beta-lactamases with all possible amino acid substitutions at residue 71.
Schultz SC; Richards JH
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1588-92. PubMed ID: 3513181
[TBL] [Abstract][Full Text] [Related]
37. Elucidating the role of Trp105 in the KPC-2 β-lactamase.
Papp-Wallace KM; Taracila M; Wallace CJ; Hujer KM; Bethel CR; Hornick JM; Bonomo RA
Protein Sci; 2010 Sep; 19(9):1714-27. PubMed ID: 20662006
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
Borgianni L; Vandenameele J; Matagne A; Bini L; Bonomo RA; Frère JM; Rossolini GM; Docquier JD
Antimicrob Agents Chemother; 2010 Aug; 54(8):3197-204. PubMed ID: 20498317
[TBL] [Abstract][Full Text] [Related]
39. Structural and computational investigations of VIM-7: insights into the substrate specificity of vim metallo-β-lactamases.
Borra PS; Leiros HK; Ahmad R; Spencer J; Leiros I; Walsh TR; Sundsfjord A; Samuelsen O
J Mol Biol; 2011 Aug; 411(1):174-89. PubMed ID: 21645522
[TBL] [Abstract][Full Text] [Related]
40. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.
Brindisi M; Brogi S; Giovani S; Gemma S; Lamponi S; De Luca F; Novellino E; Campiani G; Docquier JD; Butini S
J Enzyme Inhib Med Chem; 2016; 31(sup1):98-109. PubMed ID: 27121013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
